BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3095 related articles for article (PubMed ID: 31350295)

  • 1. The Tumor Microenvironment Innately Modulates Cancer Progression.
    Hinshaw DC; Shevde LA
    Cancer Res; 2019 Sep; 79(18):4557-4566. PubMed ID: 31350295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.
    Hadjigol S; Shah BA; O'Brien-Simpson NM
    Front Immunol; 2022; 13():894021. PubMed ID: 35784290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
    Albini A; Bruno A; Noonan DM; Mortara L
    Front Immunol; 2018; 9():527. PubMed ID: 29675018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity, inflammation and tumour progression: double-edged swords.
    Mantovani A; Ponzetta A; Inforzato A; Jaillon S
    J Intern Med; 2019 May; 285(5):524-532. PubMed ID: 30873708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy.
    Lu C; Liu Y; Ali NM; Zhang B; Cui X
    Front Immunol; 2022; 13():1039260. PubMed ID: 36741415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune cells in the tumor microenvironment.
    Li MO; Wolf N; Raulet DH; Akkari L; Pittet MJ; Rodriguez PC; Kaplan RN; Munitz A; Zhang Z; Cheng S; Bhardwaj N
    Cancer Cell; 2021 Jun; 39(6):725-729. PubMed ID: 34129817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate lymphoid cells and cancer: Role in tumor progression and inhibition.
    Yuan X; Rasul F; Nashan B; Sun C
    Eur J Immunol; 2021 Sep; 51(9):2188-2205. PubMed ID: 34189723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment.
    Jeong J; Suh Y; Jung K
    Front Immunol; 2019; 10():1817. PubMed ID: 31474975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Innate Immunity on Cancer Cell Stemness.
    Pastò A; Consonni FM; Sica A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment.
    Flores-Borja F; Irshad S; Gordon P; Wong F; Sheriff I; Tutt A; Ng T
    J Immunol Res; 2016; 2016():7803091. PubMed ID: 27882334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
    Bruno A; Mortara L; Baci D; Noonan DM; Albini A
    Front Immunol; 2019; 10():771. PubMed ID: 31057536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
    Jackaman C; Nelson DJ
    Exp Gerontol; 2014 Jun; 54():53-7. PubMed ID: 24291067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid regulatory cells in tumor spreading and metastasis.
    Keskinov AA; Shurin MR
    Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immune escape mechanisms that operate during metastasis.
    Croci DO; Salatino M
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1923-36. PubMed ID: 21470132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment.
    Russo E; Laffranchi M; Tomaipitinca L; Del Prete A; Santoni A; Sozzani S; Bernardini G
    Front Immunol; 2021; 12():787116. PubMed ID: 34975880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of systemic and local immune responses in cancer: time for integration.
    Gutkin DW; Shurin MR
    Cancer Immunol Immunother; 2014 Jan; 63(1):45-57. PubMed ID: 24100804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
    Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA
    Front Immunol; 2020; 11():1395. PubMed ID: 32733461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate lymphoid cells as regulators of the tumor microenvironment.
    Tugues S; Ducimetiere L; Friebel E; Becher B
    Semin Immunol; 2019 Feb; 41():101270. PubMed ID: 30871769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 155.